MeSH term
Frequency | Condition_Probility | Animals | 8 | 0.0 |
Aspartic Endopeptidases/*genetics | 5 | 29.0 |
Disease Models, Animal | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
*Gene Expression Regulation, Fungal | 3 | 7.0 |
Mice | 7 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 17 | 0.0 |
Adult | 4 | 0.0 |
Antigens, Fungal | 2 | 28.0 |
Comparative Study | 5 | 0.0 |
Female | 9 | 0.0 |
*Fungal Proteins | 7 | 20.0 |
Humans | 22 | 0.0 |
Male | 5 | 0.0 |
Middle Aged | 3 | 0.0 |
Aspartic Endopeptidases/immunology | 2 | 100.0 |
Aspartic Endopeptidases/genetics/*secretion | 2 | 100.0 |
Microscopy, Immunoelectron | 3 | 0.0 |
Mutation | 4 | 0.0 |
Pepstatins/pharmacology | 3 | 27.0 |
Protease Inhibitors/pharmacology | 3 | 1.0 |
Hela Cells | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Candida albicans/*enzymology | 2 | 28.0 |
Multigene Family | 2 | 0.0 |
Virulence | 5 | 2.0 |
Candida albicans/enzymology/*pathogenicity | 2 | 100.0 |
Aspartic Endopeptidases/*genetics/metabolism/secretion | 2 | 100.0 |
Candida albicans/enzymology/genetics/growth & development/*pathogenicity | 2 | 100.0 |
Candidiasis/microbiology | 2 | 33.0 |
Genes, Structural, Fungal | 2 | 8.0 |
Guinea Pigs | 2 | 0.0 |
Vaccines, Attenuated | 2 | 18.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Candidiasis, Oral/*microbiology | 2 | 33.0 |
Carrier State/*microbiology | 2 | 25.0 |
